Abstract: The present disclosure relates to an antibody binding specifically to CD55 or an antigen-binding fragment thereof; and a composition for preventing, treating and/or diagnosing cancer containing the same. The antibody of the present disclosure may be used as an effective therapeutic composition for various CD55-mediated diseases since it shows high binding ability and inhibitory effect for the CD55 protein which promotes tumor growth by inhibiting the complement immune mechanism. In addition, the antibody of the present disclosure may be usefully used as an effective therapeutic adjuvant that fundamentally removes drug resistance and remarkably improves therapeutic responsiveness in various diseases in which resistance to therapeutic agents with CDC (complement-dependent cytotoxicity) as a mechanism of action has been induced due to overexpression of CD55.

Abstract: The present invention relates to a composition for preventing, alleviating or treating sarcopenia, containing D-ribo-2-hexulose as an active ingredient. D-ribo-2-hexulose of the present invention is a sweetener capable of replacing sugar, is harmless to the human body and does not cause side effects in normal cells so as to be safe for the human body, inhibits the degradation of myoproteins, and can exhibit muscle strengthening effects by increasing muscle mass, and thus the present invention is expected to be effectively usable in the prevention, alleviation or treatment of sarcopenia.

Abstract: The present application relates to creamer comprising vegetable lipids, casein, maltose, phosphates, and allulose.

Abstract: The present application relates to an allulose-containing composition for promoting excretion of vegetable lipids from the body and a food comprising the composition of the present application and vegetable lipids.

Abstract: Provided is a composition for preventing, improving or treating obesity, which includes a Platycodon grandiflorum extract as an active ingredient and a method for preparing the extract with an improved anti-obesity effect. The extract shows an effect of inhibiting increases in body weight and fat mass caused by a high-fat diet for normalization, an increase in fasting blood glucose and a decrease in energy expenditure in a diet-induced obesity mouse model. Further, compared to an extract prepared by a conventional extraction method, the Platycodon grandiflorum extract shows a more excellent effect of inhibiting increases in body weight and fat mass, fasting blood glucose, and blood lipid and adipokine contents in experiments, resulting in an excellent anti-obesity effect. Therefore, the Platycodon grandiflorum extract prepared is expected to be useful for preventing obesity and treating obesity-related complications that can be caused by an increase in fat mass as well as obesity.

Abstract: An electronic device includes a secure element in which at least one application package is installed and a processor for communicating with the secure element. The secure element further stores a list with which a part or all of identification information of the at least one application package is registered. The processor controls the secure element such that an application package indicated by the identification information registered with the list is uninstalled, in response to a specified event. Various other embodiments recognized from the specification are also possible.

Abstract: An electronic device and a program management method therefor are provided. The electronic device includes a communication interface, a memory, at least one processor, and a secure circuitry. The secure circuitry is configured to provide a first public key stored in the secure circuitry to the at least one processor. The at least one processor is configured to transmit the first public key to an external device and receive an encrypted secure program encrypted based on the first public key and a second public key generated by the external device, from the external device. The at least one processor is further configured to transmit the second public key and the encrypted secure program to the secure circuitry. The secure circuitry is configured to decrypt the encrypted secure program based on the second public key and a first private key which is symmetrical to the first public key.

Abstract: The present application relates to an allulose-containing composition for promoting excretion of vegetable lipids from the body and a food comprising the composition of the present application and vegetable lipids.

Abstract: An electronic device includes a secure element in which at least one application package is installed and a processor for communicating with the secure element. The secure element further stores a list with which a part or all of identification information of the at least one application package is registered. The processor controls the secure element such that an application package indicated by the identification information registered with the list is uninstalled, in response to a specified event. Various other embodiments recognized from the specification are also possible.

Abstract: The present application relates to creamer comprising vegetable lipids, casein, maltose, phosphates, and allulose.

Abstract: An electronic device is provided. The electronic device includes a memory configured to store at least one application, a communication module configured to establish a connection between the electronic device and an external electronic device, and a processor configured to drive the at least one application, divide data executable by the at least one application into a first file and a second file, store the first file in the memory, and transmit the second file to the external electronic device through the communication module for storing the second file in the external electronic device.

Abstract: Provided is a composition for preventing, improving or treating obesity, which includes a Platycodon grandiflorum extract as an active ingredient and a method for preparing the extract with an improved anti-obesity effect. The extract shows an effect of inhibiting increases in body weight and fat mass caused by a high-fat diet for normalization, an increase in fasting blood glucose and a decrease in energy expenditure in a diet-induced obesity mouse model. Further, compared to an extract prepared by a conventional extraction method, the Platycodon grandiflorum extract shows a more excellent effect of inhibiting increases in body weight and fat mass, fasting blood glucose, and blood lipid and adipokine contents in experiments, resulting in an excellent anti-obesity effect. Therefore, the Platycodon grandiflorum extract prepared is expected to be useful for preventing obesity and treating obesity-related complications that can be caused by an increase in fat mass as well as obesity.

Abstract: The present invention relates to a composition for preventing or treating lipid-related metabolic diseases. The composition according to the present invention comprises D-psicose as an active ingredient. D-psicose has the ability to inhibit lipid absorption in the small intestine and considerably increase lipid levels in feces. Due to its ability, D-psicose is effective in inhibiting the formation of body fat. In addition, D-psicose reduces body weight, body fat mass, and plasma lipid to normal levels to normalize body weight, body fat mass, and plasma lipid profiles. Due to these advantages, D-psicose is expected to find application in pharmaceutical drugs, health functional foods, and functional foods suitable for preventing and/or treating lipid-related metabolic diseases.

Abstract: An electronic device is provided. The electronic device includes a processor, a memory configured to connect to the processor, and an embedded secure element (eSE) configured to connect to the processor over a physical channel to receive secure data sent by the processor over the physical channel, and store the secure data.

Abstract: An electronic device and a program management method therefor are provided. The electronic device includes a communication interface, a memory, at least one processor, and a secure circuitry. The secure circuitry is configured to provide a first public key stored in the secure circuitry to the at least one processor. The at least one processor is configured to transmit the first public key to an external device and receive an encrypted secure program encrypted based on the first public key and a second public key generated by the external device, from the external device. The at least one processor is further configured to transmit the second public key and the encrypted secure program to the secure circuitry. The secure circuitry is configured to decrypt the encrypted secure program based on the second public key and a first private key which is symmetrical to the first public key.

Abstract: An electronic device is provided. The electronic device includes a processor, a memory configured to connect to the processor, and secure circuitry configured to connect to the processor over a physical channel receive data sent by the processor over the physical channel, and store the data.

Abstract: An electronic device is provided. The electronic device includes a memory configured to store at least one application, a communication module configured to establish a connection between the electronic device and an external electronic device, and a processor configured to drive the at least one application, divide data executable by the at least one application into a first file and a second file, store the first file in the memory, and transmit the second file to the external electronic device through the communication module for storing the second file in the external electronic device.

Abstract: An image forming apparatus includes a photoconductor, a light scanning unit to irradiate light corresponding to image information, to the photoconductor so as to form an electrostatic latent image, and a developing unit arranged adjacent to an optical path of the light emitted from the light scanning unit and serving to feed developer to the photoconductor on which the electrostatic latent image is formed so as to form a visible image.

Abstract: An image forming apparatus includes a photoconductor, a light scanning unit to irradiate light corresponding to image information, to the photoconductor so as to form an electrostatic latent image, and a developing unit arranged adjacent to an optical path of the light emitted from the light scanning unit and serving to feed developer to the photoconductor on which the electrostatic latent image is formed so as to form a visible image.